Datasheet | March 22, 2022

Translational Science And Innovation Laboratory (TSAIL)

Source: Q2 Solutions
laboratory scientist laptop GettyImages-1302454417

In today's evolving, dynamic clinical development environment, central laboratories must adapt to meet the growing demand for early biomarker evaluation before advancement into clinical trials. Bringing biomarkers or novel technologies, into clinical research is becoming increasingly complex and often calls for exploratory biomarker research and new technology evaluation outside the regulatory confines of clinical trials.

At Q² Solutions, our dedicated, state-of-the-art Translational Science and Innovation Laboratory (TSAIL) is designed to address these challenges and provide the agility and breadth of translational science capabilities and expertise required to bridge the gap between preclinical and early clinical drug development and to introduce new biomarker-assays into clinical study.  Download to learn more about Q² Solutions TSAIL services.

VIEW THE DATASHEET!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Clinical Leader